Topical Soft Tissue Treatment Technology

Award Information
Agency:
Department of Defense
Branch:
Army
Amount:
$999,856.00
Award Year:
2013
Program:
SBIR
Phase:
Phase II
Contract:
W81XWH-12-C-0031
Agency Tracking Number:
A2-5438
Solicitation Year:
2011
Solicitation Topic Code:
A11-103
Solicitation Number:
2011.2
Small Business Information
Physical Optics Corporation
Photonic Systems Division 1845 West 205th Street, Torrance, CA, 90501-1510
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
000000000
Principal Investigator
 Anya Asanbaeva
 Director
 (310) 320-3088
 psproposals@poc.com
Business Contact
 Gordon Drew
Title: Chief Financial Officer
Phone: (310) 320-3088
Email: gedrew@poc.com
Research Institution
N/A
Abstract
Development of readily forward-deployable therapeutic measures to enhance wound healing and skin graft survival could promote earlier restoration to health and return to duty. To address the Armys need for a topical wound treatment with recombinant heat shock proteins (rHSPs) that can be applied to wounds to promote wound healing and skin graft survival, Physical Optics Corporation (POC) proposes to develop a new topical soft tissue treatment (TOSTT) technology. The applied TOSTT releases rHSPs into the extracellular compartment of the wound where they come into direct contact with cellular components essential to the repair process. Development of TOSTT may enhance healing and skin graft survival for complex wounds caused by injury or disease. In Phase I, POC developed the formulation and demonstrated its efficacy to accelerate wound healing and extend skin graft survival in pilot animal studies. In Phase II, further therapeutic evaluation and elucidation of the mechanism of TOSTTs action on extended skin graft survival in in vivo murine and porcine models as well as an in vitro human skin model will be performed.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government